HDAC6 and central nervous system cancer: Initially, the probe remains inactive, but upon activation by overexpressed HDAC6 in glioma cells, it releases methylene blue, which inhibits MAO A and restores the probe’s near-infrared fluorescence and photodynamic therapy activity when exposed to near-infrared light.